Aldeyra Therapeutics: Key Inflection Point Ahead

Group 1 - The Biotech Forum, led by Bret, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat discussions and weekly market commentary [1][2] - Recent discussions in The Biotech Forum have focused on profitable buy-write or covered call strategies for selected biotech stocks [2] - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is highlighted as being on the verge of commercialization, with a significant inflection point expected in April of the following year [5]